JHIU
CMD

Janus Henderson Investors US’s Cantel Medical Corporation CMD Stock Holding History

Janus Henderson Investors US’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$220K Sell
2,750
-29
-1% -$2.31K ﹤0.01% 1140
2016
Q4 		$219K Buy
+2,779
New +$216K ﹤0.01% 1179

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Investors US's CMD Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Cantel Medical Corporation (CMD) stake by 1% in Q1 2017, selling an estimated $2.31K and leaving 2,750 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Janus Henderson Investors US first reported a position in CMD in Q4 2016 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold CMD as of Q1 2017.

  • Janus Henderson Investors US held 2,750 shares of Cantel Medical Corporation worth $220K as of Q1 2017.
  • Janus Henderson Investors US sold 29 Cantel Medical Corporation shares in Q1 2017, an estimated $2.31K.
  • Cantel Medical Corporation made up ﹤0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #1140 holding.
  • Janus Henderson Investors US first reported a position in Cantel Medical Corporation in Q4 2016 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.